Cysteinyl leukotriene 2 receptor‐mediated vascular permeability via transendothelial vesicle transport

No abstract is available for this paper.

• Publication year

  2008

• Venue

  The FASEB Journal

• Publication date

  2008-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1096/fj.08-113274PMID 18779380
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury.

  2008influential reference
• Spatiotemporal Relationship Between Intracellular Ca2+ Dynamics and Wave Fragmentation During Ventricular Fibrillation in Isolated Blood-Perfused Pig Hearts

  2007cited by this paper
• G‐protein‐coupled receptors: an update

  2007cited by this paper
• Calcium signaling and exocytosis in adrenal chromaffin cells.

  2006cited by this paper
• The inflammatory response: an efficient way of life.

  2006cited by this paper
• Homocysteine causes cerebrovascular leakage in mice.

  2006cited by this paper
• Cell response to surgery.

  2006cited by this paper
• “Kiss-and-Run” Exocytosis in Astrocytes

  2006cited by this paper
• The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl‐leukotrienes receptor

  2006influential reference
• Signaling mechanisms regulating endothelial permeability.

  2006influential reference
• Ca2+-Dependent Mechanisms of Presynaptic Control at Central Synapses

  2006cited by this paper
• Calcium microdomains in regulated exocytosis.

  2006cited by this paper
• The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis.

  2005cited by this paper
• Leukotriene modifiers as potential therapeutics for cardiovascular disease

  2005cited by this paper
• Targeted Gene Disruption Reveals the Role of the Cysteinyl Leukotriene 2 Receptor in Increased Vascular Permeability and in Bleomycin-induced Pulmonary Fibrosis in Mice*

  2004cited by this paper
• Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis.

  2004cited by this paper
• Directed Vascular Expression of Human Cysteinyl Leukotriene 2 Receptor Modulates Endothelial Permeability and Systemic Blood Pressure

  2004influential reference
• Functional and morphological studies of protein transcytosis in continuous endothelia.

  2004cited by this paper
• The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke

  2004cited by this paper
• Fibered Confocal Fluorescence Microscopy (Cell-viZio™) Facilitates Extended Imaging in the Field of Microcirculation

  2004cited by this paper
• Mesenteric microvascular inflammatory responses to systemic hypoxia are mediated by PAF and LTB4.

  2003cited by this paper
• Differential Leukotriene Receptor Expression and Calcium Responses in Endothelial Cells and Macrophages Indicate 5-Lipoxygenase–Dependent Circuits of Inflammation and Atherogenesis

  2003influential reference
• Myosin Light Chain Kinase-Dependent Microvascular Hyperpermeability in Thermal Injury

  2003cited by this paper
• Characterization of Mouse Cysteinyl Leukotriene Receptors mCysLT1 and mCysLT2

  2002cited by this paper
• Soluble L-selectin attenuates tumor necrosis factor-&agr;-mediated leukocyte adherence and vascular permeability: A protective role for elevated soluble L-selectin in sepsis*

  2002cited by this paper
• Increased Endothelial Vesicular Transport Correlates with Increased Blood‐Tumor Barrier Permeability Induced by Bradykinin and Leukotriene C4

  2002cited by this paper
• Absence of Fer Protein-Tyrosine Kinase Exacerbates Leukocyte Recruitment in Response to Endotoxin1

  2002cited by this paper
• Intracellular calcium buffering shapes calcium oscillations in Xenopus melanotropes

  2001cited by this paper
• Prostaglandins and leukotrienes: advances in eicosanoid biology.

  2001cited by this paper
• The Murine Cysteinyl Leukotriene 2 (CysLT2) Receptor

  2001cited by this paper
• Cell phenotype as a target of drug therapy in chronic inflammatory diseases.

  2000cited by this paper
• Characterization of the Human Cysteinyl Leukotriene 2 Receptor*

  2000cited by this paper
• Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist.

  2000cited by this paper
• Ultrastructural and ultracytochemical features of secretory granules in the ampullary epithelium of the hamster oviduct

  1999cited by this paper
• Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: role of protein kinases, calcium, and RhoA.

  1998cited by this paper
• Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases.

  1995cited by this paper
• Thapsigargin discharges intracellular calcium stores and induces transmembrane currents in human endothelial cells

  1993cited by this paper
• Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis

  1986cited by this paper
• Kiss and Run

  1986cited by this paper
• Characterization of Mouse Cysteinyl Leukotriene Receptors mCysLT 1 and mCysLT 2 DIFFERENTIAL PHARMACOLOGICAL PROPERTIES AND TISSUE DISTRIBUTION*

  year unknowncited by this paper

• Unraveling cysteinyl leukotrienes and their receptors in inflammation through the brain-gut-lung axis

  2025cites this paper
• The role of signaling pathways mediated by the GPCRs CysLTR1/2 in melanocyte proliferation and senescence

  2024cites this paper
• Distribution of the cysteinyl leukotriene system components in the human, rat and mouse eye.

  2023cites this paper
• Targeting Mammalian 5-Lipoxygenase by Dietary Phenolics as an Anti-Inflammatory Mechanism: A Systematic Review

  2021cites this paper
• G Protein–Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action

  2020cites this paper
• [Leukotriene D4 bronchial provocation test for detection of airway hyper-responsiveness in children].

  2020cites this paper
• Targeting Leukotrienes as a Therapeutic Strategy to Prevent Comorbidities Associated with Metabolic Stress.

  2020cites this paper
• Leukotrienes in Tumor-Associated Inflammation

  2020cites this paper
• A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes

  2020cites this paper
• Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases.

  2019cites this paper
• Synopsis of arachidonic acid metabolism: A review

  2018cites this paper
• Leukotriene receptors as potential therapeutic targets

  2018cites this paper
• Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review.

  2018cites this paper
• Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases

  2018cites this paper
• IP3 receptor signaling and endothelial barrier function

  2017cites this paper
• Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases

  2017cites this paper
• Cysteinyl Leukotrienes and Their Receptors: Potential Roles in Endothelial Function and Cancer

  2016influential citation
• The modulation of smooth muscle contractility by specialised pro-resolving mediators

  2016cites this paper
• Thrombocytopathy leading to impaired in vivo haemostasis and thrombosis in platelet type von Willebrand disease

  2016cites this paper
• Cytochrome P450 and Lipoxygenase Metabolites on Renal Function.

  2015cites this paper
• Eicosanoid storm in infection and inflammation

  2015cites this paper
• HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.

  2015cites this paper
• Multiple-Site Activation of the Cysteinyl Leukotriene Receptor 2 Is Required for Exacerbation of Ischemia/Reperfusion Injury

  2014influential citation
• The Regulation and Perturbation of Vascular Endothelial Permeability

  2014cites this paper
• Cysteinyl leukotrienes regulate endothelial cell inflammatory and proliferative signals through CysLT2 and CysLT1 receptors

  2013cites this paper
• Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke

  2013cites this paper
• HAMI 3379, a CysLT2 Receptor Antagonist, Attenuates Ischemia-Like Neuronal Injury by Inhibiting Microglial Activation

  2013cites this paper
• The leukotrienes: immune-modulating lipid mediators of disease.

  2012cites this paper
• Co‐regulation of Transcellular and Paracellular Leak Across Microvascular Endothelium By Dynamin and Rac

  2012cites this paper
• Porcine Leukocyte 12-Lipoxygenase

  2012cites this paper
• The cysteinyl leukotriene 2 receptor mediates retinal edema and pathological neovascularization in a murine model of oxygen‐induced retinopathy

  2012cites this paper
• Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats.

  2012cites this paper
• Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

  2012cites this paper
• Changes in the anti-inflammatory activity of soy isoflavonoid genistein versus genistein incorporated in two types of cyclodextrin derivatives

  2012cites this paper
• A Selective Cysteinyl Leukotriene Receptor 2 Antagonist Blocks Myocardial Ischemia/Reperfusion Injury and Vascular Permeability in Mice

  2011cites this paper
• Atrial natriuretic peptide enhances microvascular albumin permeability by the caveolae-mediated transcellular pathway

  2011influential citation
• Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease.

  2011cites this paper
• Characterization of the cysteinyl leukotriene 2 receptor in novel expression sites of the gastrointestinal tract.

  2011cites this paper
• Leukotriene receptors.

  2011cites this paper
• Differential Signaling of Cysteinyl Leukotrienes and a Novel Cysteinyl Leukotriene Receptor 2 (CysLT2) Agonist, N-Methyl-Leukotriene C4, in Calcium Reporter and β Arrestin Assays

  2011influential citation
• International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions

  2011cites this paper
• Cysteinyl leukotriene receptor 2 is spatiotemporally involved in neuron injury, astrocytosis and microgliosis after focal cerebral ischemia in rats.

  2011cites this paper
• Immunopharmacological role of the Leukotriene Receptor Antagonists and inhibitors of leukotrienes generating enzymes in Multiple Sclerosis

  2010cites this paper
• Pathogenic Importance of Cysteinyl Leukotrienes in Development of Gastric Lesions Induced by Ischemia/Reperfusion in Mice

  2010cites this paper
• Arachidonic Acid Metabolism Regulates Escherichia coli Penetration of the Blood-Brain Barrier

  2010cites this paper
• Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT2) receptor

  2010influential citation
• Regioselective Copper-Mediated Organometallic Ring Openings of Acylnitroso Cycloadducts and the Development of 5-Lipoxygenase Inhibitors

  2009cites this paper
• Neutrophil granule proteins tune monocytic cell function.

  2009cites this paper
• Leukotriene D4 activates β2-integrin adhesion in human polymorphonuclear leukocytes

  2009cites this paper
• FLAP inhibitors for the treatment of inflammatory diseases.

  2009cites this paper
• Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability.

  2009cites this paper
• Cysteinyl-leukotriene receptor antagonist montelukast decreases blood–brain barrier permeability but does not prevent oedema formation in traumatic brain injury

  2009cites this paper
• Pathogenic Importance of Cysteinyl Leukotrienes in Development of Gastric Lesions Induced by Ischemia/Reperfusion in Mice

  2009cites this paper
• Endothelial cysteinyl leukotriene 2 receptor expression and myocardial ischemia/reperfusion injury.

  2008influential citation